Safety of Live-attenuated Influenza Vaccine (LAIV, Flumist) in Patients With Cystic Fibrosis (CF)
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2019
Price : $35 *
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 15 Sep 2014 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified September 2014).
- 15 Sep 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.